NRX Pharmaceuticals (NRXP) Intangibles (2025 - 2026)

NRX Pharmaceuticals' (NRXP) quarterly Intangibles came in at $879000.0 in Q1 2026, down 4.97% on a QoQ basis from $925000.0 in Q4 2025.

NRX Pharmaceuticals (NRXP) Intangibles (2025 - 2026) Analysis & Trends

NRX Pharmaceuticals (NRXP) has 2 years of Intangibles data on file, last reported at $879000.0 in Q1 2026.

On a quarterly basis, Intangibles changed N/A year-over-year to $879000.0 in Q1 2026; TTM through Mar 2026 was $879000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $925000.0, changed N/A from the prior year.
Intangibles for Q1 2026 stood at $879000.0, down from $925000.0 in the prior quarter.
Over the last five years, Intangibles for NRXP reached as high as $1.8 million in Q3 2025 and fell as low as $879000.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Intangibles (Qtr)
1	Oculis Holding AG	67,402.79 Bn	67,402.51 Bn	-	16.97 Mn
2	Nanobiotix	1,930.72 Bn	1,930.66 Bn	-	11,640.44
3	Akari Therapeutics	1,132.35 Bn	1,132.35 Bn	-	30.30 Mn
4	BeOne Medicines	471.98 Bn	467.19 Bn	1.35 Bn	61.68 Mn
5	Vertex Pharmaceuticals	123.50 Bn	116.25 Bn	2.59 Bn	418.50 Mn
6	Regeneron Pharmaceuticals	70.37 Bn	61.61 Bn	3.31 Bn	1.29 Bn
7	Belite Bio	62.41 Bn	62.41 Bn	-	-
8	Argenx Se	56.13 Bn	50.94 Bn	1.41 Bn	266.00 Mn
9	Revolution Medicines	37.51 Bn	37.51 Bn	-	55.80 Mn
10	NRX Pharmaceuticals	120.25 Mn	113.55 Mn	437,000.00	879,000.00

Download Data